NCARDIA

In News

The Future of Allogeneic Cell Therapy is Off-the-Shelf and iPSC-Based – An Interview with Cellistic’s Founder and CTO, Stefan Braam, PhD - BioInformant

BioInformant - Oct 23, 2025

New platform to accelerate cardiac drug development - Leids Universitair Medisch Centrum | LUMC

Leids Universitair Medisch Centrum | LUMC - Jan 22, 2026

Ncardia Launches First-of-Its-Kind iPSC-Derived Non-Human Primate Cardiomyocytes to Advance Cardiac Safety Research - DutchNews.nl

DutchNews.nl - Sep 23, 2025

iPSC technology company Ncardia receives US$60 million investment - RegMedNet

RegMedNet - Nov 17, 2021

Ncardia inks $60M funding deal to expand discovery and commercial production services for stem cells - Fierce Biotech

Fierce Biotech - Nov 16, 2021

Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings - Business Wire

Business Wire - Nov 16, 2021

Ncardia Expands iPSC Manufacturing and Phenotypic Drug Discovery Services With Support From Investors - PR Newswire

PR Newswire - Jul 15, 2019

Ncardia hires Holt as chief commercial officer - Medical Marketing and Media

Medical Marketing and Media - Feb 24, 2022

Ncardia Launches Cellistic™, the Only iPSC-based Cell Therapy Process Development & Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today - BioInformant

BioInformant - Apr 26, 2022

Ncardia announces completion of €10.5M Investment Round - InnovationQuarter

InnovationQuarter - Nov 17, 2017

Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transaction - Business Wire

Business Wire - Sep 20, 2022

Veronique Joubert Appointed as Chief Human Resources Officer ad interim at Ncardia and Cellistic - hrtoday.in

hrtoday.in - May 31, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment